中文版 | English
题名

Berbamine promotes macrophage autophagy to clear Mycobacterium tuberculosis by regulating the ROS/Ca2+ axis

作者
通讯作者Xu, Yuzhong; Zhang, Guoliang
发表日期
2023-06-01
DOI
发表期刊
ISSN
2150-7511
卷号14期号:4
摘要
["It is urgent to develop novel treatment strategies against drug-resistant TB, and HDT provides a promising approach to fight drug-resistant TB by repurposing old drugs. Our studies demonstrate, for the first time, that BBM, an FDA-approved drug, not only potently inhibits intracellular drug-sensitive Mtb growth but also restricts drug-resistant Mtb by promoting macrophage autophagy. Mechanistically, BBM activates macrophage autophagy by regulating the ROS/Ca2+ axis. In conclusion, BBM could be considered as an HDT candidate and may contribute to improving the outcomes or shortening the treatment course of drug-resistant TB.","Drug-resistant tuberculosis (TB) poses a major threat to global TB control; consequently, there is an urgent need to develop novel anti-TB drugs or strategies. Host-directed therapy (HDT) is emerging as an effective treatment strategy, especially for drug-resistant TB. This study evaluated the effects of berbamine (BBM), a bisbenzylisoquinoline alkaloid, on mycobacterial growth in macrophages. BBM inhibited intracellular Mycobacterium tuberculosis (Mtb) growth by promoting autophagy and silencing ATG5, partially abolishing the inhibitory effect. In addition, BBM increased intracellular reactive oxygen species (ROS), while the antioxidant N-acetyl-L-cysteine (NAC) abolished BBM-induced autophagy and the ability to inhibit Mtb survival. Furthermore, the increased intracellular Ca2+ concentration induced by BBM was regulated by ROS, and BAPTA-AM, an intracellular Ca2+-chelating agent, could block ROS-mediated autophagy and Mtb clearance. Finally, BBM could inhibit the survival of drug-resistant Mtb. Collectively, these findings provide evidence that BBM, a Food and Drug Administration (FDA)-approved drug, could effectively clear drug-sensitive and -resistant Mtb through regulating ROS/Ca2+ axis-mediated autophagy and has potential as an HDT candidate for TB therapy. IMPORTANCEIt is urgent to develop novel treatment strategies against drug-resistant TB, and HDT provides a promising approach to fight drug-resistant TB by repurposing old drugs. Our studies demonstrate, for the first time, that BBM, an FDA-approved drug, not only potently inhibits intracellular drug-sensitive Mtb growth but also restricts drug-resistant Mtb by promoting macrophage autophagy. Mechanistically, BBM activates macrophage autophagy by regulating the ROS/Ca2+ axis. In conclusion, BBM could be considered as an HDT candidate and may contribute to improving the outcomes or shortening the treatment course of drug-resistant TB."]
关键词
相关链接[来源记录]
收录类别
语种
英语
学校署名
第一 ; 通讯
资助项目
National Key Research and Development Plan[2021YFA1300902] ; National Natural Science Foundation of China["82170009","82100013"] ; Guangdong Scientific and Technological Foundation["2019B1515120041","2020B1111170014"] ; Guangxi Scientific and Technological Foundations[AA22096027] ; Shenzhen Scientific and Technological Foundations["KCXFZ20211020163545004","KCXFZ202002011007083","JCYJ20190809104205706","JCYJ20180228162321234"]
WOS研究方向
Microbiology
WOS类目
Microbiology
WOS记录号
WOS:001023845600001
出版者
来源库
Web of Science
引用统计
被引频次[WOS]:4
成果类型期刊论文
条目标识符http://sustech.caswiz.com/handle/2SGJ60CL/549368
专题南方科技大学第二附属医院
南方科技大学第一附属医院
作者单位
1.Southern Univ Sci & Technol, Shenzhen Peoples Hosp 3, Natl Clin Res Ctr Infect Dis, Guangdong Prov Clin Res Ctr TB, Shenzhen, Peoples R China
2.Guangzhou Med Univ, Guangzhou, Peoples R China
3.Shenzhen Univ, Baoan Peoples Hosp Shenzhen, Affiliated Hosp 2, Dept Clin Lab, Shenzhen, Peoples R China
4.Guangxi Chest Hosp, Dept TB, Liuzhou, Peoples R China
第一作者单位南方科技大学第二附属医院;  南方科技大学第一附属医院
通讯作者单位南方科技大学第二附属医院;  南方科技大学第一附属医院
第一作者的第一单位南方科技大学第二附属医院;  南方科技大学第一附属医院
推荐引用方式
GB/T 7714
Zhang, Su,Zhou, Xuefeng,Ou, Min,et al. Berbamine promotes macrophage autophagy to clear Mycobacterium tuberculosis by regulating the ROS/Ca2+ axis[J]. MBIO,2023,14(4).
APA
Zhang, Su.,Zhou, Xuefeng.,Ou, Min.,Fu, Xiangdong.,Lin, Qiao.,...&Zhang, Guoliang.(2023).Berbamine promotes macrophage autophagy to clear Mycobacterium tuberculosis by regulating the ROS/Ca2+ axis.MBIO,14(4).
MLA
Zhang, Su,et al."Berbamine promotes macrophage autophagy to clear Mycobacterium tuberculosis by regulating the ROS/Ca2+ axis".MBIO 14.4(2023).
条目包含的文件
条目无相关文件。
个性服务
原文链接
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
导出为Excel格式
导出为Csv格式
Altmetrics Score
谷歌学术
谷歌学术中相似的文章
[Zhang, Su]的文章
[Zhou, Xuefeng]的文章
[Ou, Min]的文章
百度学术
百度学术中相似的文章
[Zhang, Su]的文章
[Zhou, Xuefeng]的文章
[Ou, Min]的文章
必应学术
必应学术中相似的文章
[Zhang, Su]的文章
[Zhou, Xuefeng]的文章
[Ou, Min]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
[发表评论/异议/意见]
暂无评论

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。